Henan Lingrui Pharmaceutical Co., Ltd. provided earnings guidance for the full year 2015. For the period, the company expects year-on-year increase of between 65% and 85% in its net profit owned by shareholders.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.96 CNY | -1.80% |
|
-6.70% | +34.19% |
13/05 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
25/04 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.19% | 1.82B | |
+7.30% | 4.81B | |
-31.08% | 3.6B | |
-0.71% | 3.09B | |
-24.32% | 2.62B | |
-11.35% | 2.27B | |
+33.49% | 1.41B | |
-15.07% | 1.38B | |
+40.95% | 1.37B | |
-25.94% | 1.29B |
- Stock Market
- Equities
- 600285 Stock
- News Henan Lingrui Pharmaceutical Co., Ltd.
- Henan Lingrui Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Full Year 2015